US Patent 10577416 Mica binding agents
Patent 10577416 was granted and assigned to Innate Pharma on March, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+430 characters)
Article
Patent abstract
The present invention relates to methods for the treatment of disorders mediated by MICA-expressing cells using antibodies, antibody fragments, and derivatives thereof that specifically bind MICA. The invention also relates to antibodies; cells producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; and pharmaceutical compositions comprising the same.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Cecile Bonnafous0
Ivan Perrot0
Laurent Gauthier0
Mathieu Blery0
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105774160
Date of Patent
March 3, 2020
0Patent Application Number
143772740
Date Filed
February 7, 2013
0Patent Citations Received
Patent Primary Examiner
Edits on 6 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10577416 Mica binding agents
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10577416
Date of patent
March 3, 2020
Patent application number
14377274
Date Filed
February 7, 2013
Patent primary examiner
Find more entities like US Patent 10577416 Mica binding agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.